← Back

Arjo AB

Arjo AB (publ) develops and sells medical devices and solutions for clinical and financial outcomes in healthcare across Europe, Asia, Latin America, Africa, and the Pacific. Its offerings include patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, blood clot prevention, and leg ulcer treatment, as well as obstetric and cardiac diagnostics. The company also provides dementia care, bariatric room solutions, prone positioning, early mobility, rehabilitation services, equipment repair and maintenance, and equipment rental and financing. Founded in 1957 and headquartered in Malmö, Sweden, Arjo serves private and public institutions providing acute and long-term care.

Price · split & dividend adjusted
News & notes moving 0HQ8.LSE
0HQ8.LSE

Arjo Q2 profit rises to SEK 125 million, maintains 2026 sales growth outlook

Arjo reported higher second-quarter net income, with profit attributable to shareholders rising to SEK 125 million from SEK 92 million a year earlier. Earnings per share increased to SEK 0.46 from SEK 0.34, while adjusted EBITDA edged up to SEK 482 million from SEK 475 million. Operating profit surged to SEK 211 million from SEK 174 million, and net sales grew to SEK 2.76 billion from SEK 2.68 billion. The company maintained its 2026 organic sales growth outlook of 3% to 5%.
RTTNews·67dRead more →